{"id":"W4394690662","doi":"10.1136/jitc-2023-007675","title":"Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy","year":2024,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Université de Montréal","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; Eli Lilly Canada; National Institutes of Health; Bausch Health; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Galderma; Amryt Pharma; Incyte; Novocure; Sanofi; Amgen; Pfizer; Les Laboratories Pierre Fabre","keywords":"Medicine; CLARITY; Delphi method; Adverse effect; Grading (engineering); Usability; Medical diagnosis; Family medicine; Disease; Psoriasis; MEDLINE; Vitiligo; Alternative medicine; Dermatology; Internal medicine; Pathology; Artificial intelligence; Computer science","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1395355,0.001609061,0.002010543,0.01516802,0.003327806,0.005727045,0.004759449,0.00305074,0.002467322],"category_scores_gemma":[0.1634588,0.0007677777,0.004721673,0.00683884,0.004291485,0.006384556,0.01247787,0.00661149,0.001698311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007779453,"about_ca_system_score_gemma":0.01970476,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004895435,"about_ca_topic_score_gemma":0.007992923,"domain_scores_codex":[0.7982502,0.1131389,0.05433246,0.005169509,0.0260808,0.00302811],"domain_scores_gemma":[0.8313652,0.06534542,0.03064595,0.00699461,0.05996603,0.005682739],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009508491,0.0008806501,0.1256228,0.01790829,0.000878225,0.00113599,0.03016814,0.006247246,0.005589484,0.06572998,0.1547969,0.5900915],"study_design_scores_gemma":[0.000714161,0.002471382,0.1496789,0.03310813,0.001196478,0.01098225,0.03446148,0.02010475,0.006142035,0.09091926,0.6491076,0.001113475],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.1180059,0.04555382,0.5940645,0.07144754,0.005043596,0.04132408,0.009976925,0.00176751,0.1128162],"genre_scores_gemma":[0.2421175,0.01030318,0.7068498,0.007840579,0.0007136969,0.02162982,0.006551914,0.0003330928,0.003660444],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.1395355,"threshold_uncertainty_score":0.737943,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04581985567053431,"score_gpt":0.340229610841648,"score_spread":0.2944097551711137,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}